Trial Phase
Trial Status
Paid Participation
Clear All
13 Multiple Sclerosis Trials near Minnesota
Power is an online platform that helps thousands of Multiple Sclerosis patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerFrexalimab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
858 Participants Needed
Frexalimab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
1400 Participants Needed
Ofatumumab + Siponimod vs Fingolimod for Pediatric Multiple Sclerosis
Trial Details
Key Eligibility Criteria
129 Participants Needed
Stem Cell Transplant vs Best Available Therapy for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
156 Participants Needed
Tolebrutinib for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
2500 Participants Needed
Ublituximab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
300 Participants Needed
Tolebrutinib for Primary Progressive Multiple Sclerosis
Trial Details
Key Eligibility Criteria
767 Participants Needed
Intensive vs Escalation Therapy Approaches for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
800 Participants Needed
Obexelimab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
93 Participants Needed
Imaging Techniques for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
200 Participants Needed
Early Aggressive vs Traditional Therapy for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
900 Participants Needed
Breathing Practice for Multiple Sclerosis and Cancer
Trial Details
Key Eligibility Criteria
147 Participants Needed
RP2/RP3 + Atezolizumab + Bevacizumab for Colorectal Cancer
Trial Details
Key Eligibility Criteria
4 Participants Needed
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.